Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees
Open Access
- 15 November 2013
- journal article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 13 (1), 544
- https://doi.org/10.1186/1471-2334-13-544
Abstract
The efficacy of the H1N1 influenza vaccine relies on the induction of both humoral and cellular responses. This study evaluated the humoral and cellular responses to a monovalent non-adjuvanted pandemic influenza A/H1N1 vaccine in occupationally exposed subjects who were previously vaccinated with a seasonal vaccine.Keywords
This publication has 30 references indexed in Scilit:
- Seroprevalence of Pandemic H1N1 Antibody among Health Care Workers in Hong Kong Following Receipt of Monovalent 2009 H1N1 Influenza VaccinePLOS ONE, 2011
- Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai childrenVaccine, 2011
- Influenza A (H1N1) 2009 two-dose immunization of US children: An observer-blinded, randomized, placebo-controlled trialVaccine, 2011
- Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine.Human Vaccines, 2010
- A Rapid Immune Response to 2009 Influenza A(H1N1) Vaccines in Adults: A Randomized, Double‐Blind, Controlled TrialThe Journal of Infectious Diseases, 2010
- Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and ChildrenJAMA, 2010
- Response to a Monovalent 2009 Influenza A (H1N1) VaccineNew England Journal of Medicine, 2009
- Severe Respiratory Disease Concurrent with the Circulation of H1N1 InfluenzaNew England Journal of Medicine, 2009
- Prospects for an influenza vaccine that induces cross‐protective cytotoxic T lymphocytesImmunology & Cell Biology, 2009
- Cell-mediated Protection in Influenza InfectionEmerging Infectious Diseases, 2006